Association between serum ferritin and the insulin resistance syndrome in a representative population

被引:123
作者
Wrede, CE [1 ]
Buettner, R
Bollheimer, LC
Schölmerich, J
Palitzsch, KD
Hellerbrand, C
机构
[1] Univ Regensburg, Dept Internal Med 1, D-93042 Regensburg, Germany
[2] Hosp Neuperlach, Dept Internal Med 3, Munich, Germany
关键词
D O I
10.1530/eje.1.02083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Unexplained hepatic iron overload with increased scruin ferritin (SF) values has been associated with the insulin resistance syndrome (IRS), defined by the presence of one or more of the following criteria: increased body mass index (BMI), diabetes, hyperlipidemia or hypertension. However, as yet the association between IRS and SF in a representative population has not been investigated. Methods: The study Subjects participated in a nationwide epidemiological survey on metabolic disorders in the adult German population. The 1200 probands included in this study are representative of the German population. To eliminate major causes Of Secondary iron overload. 114 (9.5%) subjects with excessive alcohol consumption and 16 (1.5%) subjects with serological evidence for hepatitis B or C were excluded. For all remaining 1070 probands, complete clinical data of SF. HbA1c, known diabetes, BMI. cholesterol, high-density lipoprotein-cholesterol and blood pressure were available. Results: SF Values were significantly increased in men and women with high BMI (>25 kg/m(2)), increased cholesterol (>200 mg/dl), and increased systolic (>160 mmHg) blood pressure. in women with diabetes. and in men with increased diastolic (> 95 mmHg) blood pressure. Furthermore, there was a significant correlation between the number of IRS criteria and SF. Conclusions: This Study shows a significant correlation between SF and the presence of IRS criteria in a large representative Population. Interestingly, the severity of the IRS seems to be associated with increased SF levels Suggesting a Causal Connection. Further studies are required to investigate the pathophysiological mechanism and consequences of increased SF levels in patients with IRS.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 33 条
[1]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[2]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[3]   Prevalence of body iron excess in the metabolic syndrome [J].
Bozzini, C ;
Girelli, D ;
Olivieri, O ;
Martinelli, N ;
Bassi, A ;
De Matteis, G ;
Tenuti, I ;
Lotto, V ;
Friso, S ;
Pizzolo, F ;
Corrocher, R .
DIABETES CARE, 2005, 28 (08) :2061-2063
[4]   LIVER IN OBESITY [J].
BRAILLON, A ;
CAPRON, JP ;
HERVE, MA ;
DEGOTT, C ;
QUENUM, C .
GUT, 1985, 26 (02) :133-139
[5]   Definition and characterization of relative hypo- and hyperleptinemia in a large Caucasian population [J].
Buettner, R ;
Bollheimer, LC ;
Zietz, B ;
Drobnik, W ;
Lackner, K ;
Schmitz, G ;
Schölmerich, J ;
Palitzsch, KD .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (03) :745-756
[6]   INSULIN RESISTANCE AND IRON OVERLOAD [J].
DANDONA, P ;
HUSSAIN, MAM ;
VARGHESE, Z ;
POLITIS, D ;
FLYNN, DM ;
HOFFBRAND, AV .
ANNALS OF CLINICAL BIOCHEMISTRY, 1983, 20 (MAR) :77-79
[7]   Blood letting in high-ferritin type 2 diabetes -: Effects on insulin sensitivity and β-cell function [J].
Fernández-Real, JM ;
Peñarroja, G ;
Castro, A ;
García-Bragado, F ;
Hernández-Aguado, D ;
Ricart, W .
DIABETES, 2002, 51 (04) :1000-1004
[8]   Body mass index, diabetes, and C-reactive protein among US adults [J].
Ford, ES .
DIABETES CARE, 1999, 22 (12) :1971-1977
[9]   Diabetes and serum ferritin concentration among US adults [J].
Ford, ES ;
Cogswell, ME .
DIABETES CARE, 1999, 22 (12) :1978-1983
[10]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359